EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China

Yun Xie, Quanzhong Liu, Li Li, Baoxi Wang, Jiaming Sun, Hongyi Zhao, Qing Guo, Juan Su, Xiaojing Fan, Hui Wang, Lei Ge, Xingli Wang und 1 weitere

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2024-12 · 99 · 67-75

DOI: 10.1016/j.bjps.2024.09.012 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2024-12. Verfasst von Yun Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Forehead, Neuromuscular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ASkin AgingForeheadNeuromuscular AgentsHumansDouble-Blind MethodMaleFemaleChinaMiddle AgedAdultInjections, IntramuscularTreatment Outcome

Stichwörter der Autor:innen

ChinaDaxibotulinumtoxinA for injectionEfficacyGlabellar linesSafety

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Tianjing Medical University General Hospital, Tianjing, China.
  • West China Hospital, Sichuan University, Chengdu, China.
  • Plastic Surgery Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Plastic Surgery of Beijing Hospital, National Center for Geriatrics, Chinese Academy of Medical Sciences Institute of Geriatrics, Beijing Hospital, Beijing, China.

Zitieren

APA

Xie, Y., Liu, Q., Li, L., Wang, B., Sun, J., Zhao, H., Guo, Q., Su, J., Fan, X., Wang, H., Ge, L., Wang, X., & Li, Q. (2024). DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China. Journal of Plastic, Reconstructive & Aesthetic Surgery, 99, 67-75. https://doi.org/10.1016/j.bjps.2024.09.012

Vancouver

Xie Y, Liu Q, Li L, Wang B, Sun J, Zhao H, et al. DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024;99:67-75. doi:10.1016/j.bjps.2024.09.012

BibTeX
@article{Xie2024,
  author = {Xie, Yun and Liu, Quanzhong and Li, Li and Wang, Baoxi and Sun, Jiaming and Zhao, Hongyi and Guo, Qing and Su, Juan and Fan, Xiaojing and Wang, Hui and Ge, Lei and Wang, Xingli and Li, Qingfeng},
  title = {DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2024},
  volume = {99},
  pages = {67--75},
  doi = {10.1016/j.bjps.2024.09.012}
}
Kostenlos starten →